09:19 AM EDT, 06/20/2025 (MT Newswires) -- Health care stocks were rising premarket Friday with the iShares Biotechnology ETF (IBB) up 0.9% and the Health Care Select Sector SPDR Fund ( XLV ) 0.3% higher recently.

Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said the US Food and Drug Administration approved Dupixent for the treatment of adult patients with bullous pemphigoid. Shares of Sanofi ( SNY ) and Regeneron Pharmaceuticals ( REGN ) were up 1% pre-bell.

Madrigal Pharmaceuticals ( MDGL ) shares were up nearly 2% after the company said it received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for resmetirom to treat noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.

Evolent Health ( EVH ) shares were nearly 2% higher after the company reiterated its Q2 and 2025 adjusted earnings before interest, taxes, depreciation and amortization guidance.